Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogentm Attunetm Xenithtm Flow Cytometer, allowing immunology and immuno-oncology ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...